Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-02-11

Clinical Trial Update: Investigation of the Efficacy of Metformin Therapy on Pulmonary Sarcoidosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating metformin for pulmonary sarcoidosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Sarcoidosis, Pulmonary | Phase 2 | Status: WITHDRAWN